BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24585249)

  • 1. SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistance.
    Munakata K; Uemura M; Takemasa I; Ozaki M; Konno M; Nishimura J; Hata T; Mizushima T; Haraguchi N; Noura S; Ikenaga M; Okamura S; Fukunaga M; Murata K; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2014 May; 44(5):1521-8. PubMed ID: 24585249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
    Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
    Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twist mediates an aggressive phenotype in human colorectal cancer cells.
    Deng JJ; Zhang W; Xu XM; Zhang F; Tao WP; Ye JJ; Ge W
    Int J Oncol; 2016 Mar; 48(3):1117-24. PubMed ID: 26782761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression.
    Zhang GJ; Xiao HX; Tian HP; Liu ZL; Xia SS; Zhou T
    Int J Mol Med; 2013 Jun; 31(6):1375-80. PubMed ID: 23588589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
    Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
    Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SW480 colorectal cancer cells that naturally express Lgr5 are more sensitive to the most common chemotherapeutic agents than Lgr5-negative SW480 cells.
    Planutis AK; Holcombe RF; Planoutene MV; Planoutis KS
    Anticancer Drugs; 2015 Oct; 26(9):942-7. PubMed ID: 26196680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC25A, VAV1, TP73, BRCA1 and ZAP70 gene overexpression correlates with radiation response in colorectal cancer.
    Huang MY; Wang JY; Chang HJ; Kuo CW; Tok TS; Lin SR
    Oncol Rep; 2011 May; 25(5):1297-306. PubMed ID: 21344162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.
    Bellone S; Tassi R; Betti M; English D; Cocco E; Gasparrini S; Bortolomai I; Black JD; Todeschini P; Romani C; Ravaggi A; Bignotti E; Bandiera E; Zanotti L; Pecorelli S; Ardighieri L; Falchetti M; Donzelli C; Siegel ER; Azodi M; Silasi DA; Ratner E; Schwartz PE; Rutherford TJ; Santin AD
    Br J Cancer; 2013 Jul; 109(2):462-71. PubMed ID: 23807163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
    Zheng J; Sun X; Wang W; Lu S
    Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.
    Ma F; Bi L; Yang G; Zhang M; Liu C; Zhao Y; Wang Y; Wang J; Bai Y; Zhang Y
    Oncol Rep; 2014 Sep; 32(3):1071-7. PubMed ID: 25017610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
    Fang Z; Gong C; Yu S; Zhou W; Hassan W; Li H; Wang X; Hu Y; Gu K; Chen X; Hong B; Bao Y; Chen X; Zhang X; Liu H
    Cancer Lett; 2018 Feb; 415():58-72. PubMed ID: 29203250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression.
    Sun S; Yang X; Qin X; Zhao Y
    Protoplasma; 2020 May; 257(3):921-930. PubMed ID: 31933004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis.
    Li L; Shang J; Zhang Y; Liu S; Peng Y; Zhou Z; Pan H; Wang X; Chen L; Zhao Q
    Oncol Rep; 2017 Sep; 38(3):1383-1392. PubMed ID: 28731151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.
    Tanaka S; Hosokawa M; Yonezawa T; Hayashi W; Ueda K; Iwakawa S
    Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
    Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
    Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells.
    Uemura M; Yamamoto H; Takemasa I; Mimori K; Hemmi H; Mizushima T; Ikeda M; Sekimoto M; Matsuura N; Doki Y; Mori M
    Clin Cancer Res; 2010 Sep; 16(18):4636-46. PubMed ID: 20823141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
    Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
    Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway.
    Li L; Duan T; Wang X; Zhang RH; Zhang M; Wang S; Wang F; Wu Y; Huang H; Kang T
    Sci Rep; 2016 Feb; 6():20460. PubMed ID: 26847701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.